Previous 10 | Next 10 |
FARMINGDALE, NY, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the first quarter ended October 31, 2023. First Quarter Highlights The Company's Life Sciences division's fir...
Lanvin Group Holdings Limited (LANV) is expected to report for quarter end 2023-09-30 Sonnet BioTherapeutics Holdings Inc. (SONN) is expected to report for Q4 2023 Shionogi & Co. Ltd. ADR (SGIOY) is expected to report for Q2 2024 Gelesis Holdings, Inc. (GLSHQ) is expected to repor...
2023-11-11 02:30:00 ET Summary Jackson Peak is an alternative investment firm that manages a single, concentrated, long / short equity portfolio. The firm’s objective is to deliver attractive risk-adjusted, absolute returns. In Q3 2023, Jackson Peak returned +11.8% despite ...
2023-11-06 13:36:11 ET More on Enzo Biochem Enzo Biochem: Cleaned Up And Cash-Rich But Unloved Enzo Biochem names interim CEO Financial information for Enzo Biochem For further details see: Enzo Biochem GAAP EPS of $0.41
FARMINGDALE, NY, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fourth quarter ended July 31, 2023, and the fiscal year ended July 31, 2023, and also provided a general business updat...
FARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading life sciences company, announced today that Steven J. Pully has been appointed to the Company’s Board of Directors effective October 26, 2...
FNCB Bancorp Inc. (FNCB) is expected to report for Q1 2024 Civista Bancshares Inc. (CIVB) is expected to report $0.6 for Q3 2023 ASLAN Pharmaceuticals Limited (ASLN) is expected to report $-0.85 for Q3 2023 Grupo Televisa S.A. (TV) is expected to report $0.02 for Q3 2023 Red River...
2023-10-26 01:18:21 ET Summary Enzo Biochem is a microcap company with a $30 million revenue run-rate Life Sciences business and $78-$85 million in cash. The company is likely being prepared for sale, with interest from potential acquirers and activists controlling 30% of voting s...
South Plains Financial Inc. (SPFI) is expected to report $0.64 for Q3 2023 Grupo Aeroportuario Del Pacifico S.A. B. de C.V. de C.V. (each representing 10 Series B shares) (PAC) is expected to report $3.13 for Q3 2023 Himalaya Technologies Inc (HMLA) is expected to report for Q1 2024 R...
JPMorgan Chase & Co. (JPM) is expected to report $3.89 for Q3 2023 Unity Bancorp Inc. (UNTY) is expected to report $0.89 for Q3 2023 Wells Fargo & Company (WFC) is expected to report $1.25 for Q3 2023 Intellipharmaceutics International Inc (IPCIF) is expected to report for Q1 ...
News, Short Squeeze, Breakout and More Instantly...
SunPower Corporation (SPWR) is expected to report $-0.29 for Q1 2024 Siemens Healthineers AG ADR (SMMNY) is expected to report for Q2 2024 Specificity Inc Com (SPTY) is expected to report for Q1 2024 Tokyo Gas Co. Ltd. ADR (TKGSY) is expected to report for Q4 2024 Gol Linhas Aerea...
FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024. Second Quarter Highlights The Company's Life Science division's...
FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments. Summary of the Fis...